Skip to content

IMPROVING EARLY CHILDHOOD GROWTH AND DEVELOPMENT IN LOW INCOME COUNTRIES BY INCORPORATING DEWORMING PROGRAM IN INTEGRATED CHILD HEALTH CARE

IMPROVING EARLY CHILDHOOD GROWTH AND DEVELOPMENT IN LOW INCOME COUNTRIES BY INCORPORATING DEWORMING PROGRAM IN INTEGRATED CHILD HEALTH CARE

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-032-11
Enrollment
1760
Registered
2011-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

THERE WILL BE FOUR INTERVENTION GROUPS RANDOMIZED TO DIFFERENT DEWORMING SCHEDULES: 1) USUAL CARE AND DEWORMING TREATMENT AT THE 12-MONTH VISIT AND USUAL CARE AND PLACEBO AT THE 18-MONTH VISIT, 2) USU
3) USUAL CARE AND DEWORMING AT BOTH THE 12-MONTH VISIT AND THE 18-MONTH VISIT
AND 4) USUAL CARE AND PLACEBO AT BOTH THE 12 AND 18-MONTH VISITS. ALL CHILDREN WILL RECEIVE DEWORMING AT 24 MONTHS OF AGE. WEIGHT, LENGTH, DEVELOPMENT (COGNITIVE AND MOTOR) AND STH INFECTION WILL

Sponsors

Thrasher Research Fund,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: 1) CHILDREN ATTENDING ANY OF THE STUDY HEALTH CENTRES FOR THEIR 12-MONTH CRED VISIT; 2) CHILDREN LIVING IN OR NEAR THE STUDY AREA (IN IQUITOS AND NEIGHBORING COMMUNITIES).

Exclusion criteria

Exclusion criteria: 1) CHILDREN WHO ARE ATTENDING THE STUDY HEALTH CENTER FOR SUSPECTED STH INFECTION; 2) CHILDREN WHO HAVE RECEIVED DEWORMING TREATMENT OR TREATMENT USING MEDICINAL PLANTS WITH PROBABLE ANTIPARASITIC ACTIVITY IN THE SIX MONTHS PRIOR TO RANDOMIZATION; 3) PARENTS PLANNING TO MOVE OUTSIDE THE STUDY AREA WITHIN THE NEXT 12 MONTHS; 4) CHILDREN UNDER 12 MONTHS OF AGE OR OVER 14 MONTHS OF AGE; AND 5) CHILDREN WITH SERIOUS CONGENITAL OR CHRONIC MEDICAL CONDITIONS AND WHO WOULD BE CONSIDERED BY THE ATTENDING STAFF NOT TO BENEFIT FROM DEWORMING.

Countries

United States

Contacts

Public ContactEver Marlen Lazaro

ASOCIACION CIVIL SELVA AMAZONICA

elazaro@acsaperu.org065-221341

Outcome results

None listed

Source: REPEC (via WHO ICTRP)